SCHEMBL7378104

SCHEMBL7378104

COC(=O)C1=Cc2ccccc2CCC1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 3/20 0.48
CA9 Q16790 3/20 0.48
TRPA1 O75762 5/20 0.40
TSHR P16473 1/20 0.39
L3MBTL1 Q9Y468 2/20 0.38
KDM4E B2RXH2 2/20 0.38
ALDH1A1 P00352 2/20 0.38
HPGD P15428 2/20 0.38
MAPT P10636 2/20 0.38
MEN1 O00255 1/20 0.38
PLA2G1B P04054 1/20 0.38
KMT2A Q03164 1/20 0.38
ATG4B Q9Y4P1 1/20 0.38
SLC6A3 Q01959 3/20 0.38
SLC6A2 P23975 2/20 0.38
ALOX15 P16050 1/20 0.38
SLC6A4 P31645 2/20 0.37
POLB P06746 1/20 0.37
NPC1 O15118 1/20 0.36
NFKB1 P19838 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31090834 0.90 CA12 (0.50) CA12CA9TRPA1TSHRL3MBTL1
SCHEMBL7911204 0.90 CA12 (0.50) CA12CA9TRPA1TSHRL3MBTL1
SCHEMBL7714827 0.83 TSHR (0.45) CA12CA9TSHRL3MBTL1KDM4E
SCHEMBL5600204 0.81 CA12 (0.59) CA12CA9TRPA1ALOX15
SCHEMBL29476751 0.81 CA12 (0.59) CA12CA9TRPA1ALOX15
SCHEMBL7216486 0.80 CA12 (0.41) CA12CA9L3MBTL1ALDH1A1POLB
SCHEMBL6756729 0.80 MAOA (0.46) TSHRALDH1A1MAPTMEN1KMT2A
SCHEMBL7218351 0.79 CA12 (0.52) CA12CA9L3MBTL1KDM4EALDH1A1
SCHEMBL5204894 0.79 NR4A2 (0.37) CA12CA9L3MBTL1ALDH1A1MAPT
SCHEMBL7712649 0.77 RAB9A (0.46) CA12CA9TSHRL3MBTL1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1998055475-A1 GUANIDINE DERIVIATIVES AS INHIBITORS OF NA+/H+ EXCHANGE IN CELLS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-12-10 WO disclosed